US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 37.620
  • -0.830-2.16%
Close Jan 8 16:00 ET
  • 37.620
  • 0.0000.00%
Post 17:52 ET
2.24BMarket Cap13.73P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
4.68M
4.17M
254.95M
125.73%60M
60M
0
0
0
-2.84%26.58M
0
Operating revenue
--4.68M
--4.17M
--254.95M
125.73%60M
--60M
--0
--0
--0
-2.84%26.58M
--0
Cost of revenue
Gross profit
Operating expense
20.36%46.13M
1.43%42.96M
35.04%48.64M
-2.72%153.65M
1.19%36.95M
18.65%38.33M
0.12%42.35M
-23.09%36.02M
3.10%157.95M
-19.98%36.52M
Selling and administrative expenses
32.58%10.16M
2.92%9.44M
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
16.70%31.74M
-8.65%6.63M
-General and administrative expense
32.58%10.16M
2.92%9.44M
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
16.70%31.74M
-8.65%6.63M
Research and development costs
17.30%35.97M
1.02%33.52M
23.04%33.73M
-4.80%120.16M
-3.30%28.9M
20.71%30.66M
-4.13%33.18M
-24.51%27.42M
0.17%126.22M
-22.12%29.88M
Operating profit
-8.16%-41.45M
8.41%-38.79M
672.75%206.31M
28.71%-93.65M
163.12%23.05M
-18.65%-38.33M
-2.20%-42.35M
-70.63%-36.02M
-4.39%-131.37M
1.35%-36.52M
Net non-operating interest income expense
80.67%7.68M
89.22%7.4M
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
816.48%4.06M
1,745.08%2.25M
Non-operating interest income
80.67%7.68M
89.22%7.4M
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
816.48%4.06M
1,745.08%2.25M
Other net income (expense)
554.84%141K
610.53%97K
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
46.31%-80K
646.15%71K
Other non- operating income (expenses)
554.84%141K
610.53%97K
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
46.31%-80K
646.15%71K
Income before tax
1.39%-33.63M
18.64%-31.29M
724.66%210.67M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Income tax
-420K
-676K
3.33M
0
0
0
Net income
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Net income continuous Operations
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Minority interest income
Net income attributable to the parent company
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Basic earnings per share
6.90%-0.54
26.47%-0.5
608.96%3.41
46.54%-1.39
165.22%0.45
9.38%-0.58
19.05%-0.68
-55.81%-0.67
4.06%-2.6
10.39%-0.69
Diluted earnings per share
6.90%-0.54
26.47%-0.5
586.57%3.26
46.54%-1.39
163.77%0.44
9.38%-0.58
19.05%-0.68
-55.81%-0.67
4.06%-2.6
10.39%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 4.68M 4.17M 254.95M 125.73%60M 60M 0 0 0 -2.84%26.58M 0
Operating revenue --4.68M --4.17M --254.95M 125.73%60M --60M --0 --0 --0 -2.84%26.58M --0
Cost of revenue
Gross profit
Operating expense 20.36%46.13M 1.43%42.96M 35.04%48.64M -2.72%153.65M 1.19%36.95M 18.65%38.33M 0.12%42.35M -23.09%36.02M 3.10%157.95M -19.98%36.52M
Selling and administrative expenses 32.58%10.16M 2.92%9.44M 73.27%14.91M 5.52%33.49M 21.41%8.05M 11.03%7.66M 19.26%9.17M -18.16%8.61M 16.70%31.74M -8.65%6.63M
-General and administrative expense 32.58%10.16M 2.92%9.44M 73.27%14.91M 5.52%33.49M 21.41%8.05M 11.03%7.66M 19.26%9.17M -18.16%8.61M 16.70%31.74M -8.65%6.63M
Research and development costs 17.30%35.97M 1.02%33.52M 23.04%33.73M -4.80%120.16M -3.30%28.9M 20.71%30.66M -4.13%33.18M -24.51%27.42M 0.17%126.22M -22.12%29.88M
Operating profit -8.16%-41.45M 8.41%-38.79M 672.75%206.31M 28.71%-93.65M 163.12%23.05M -18.65%-38.33M -2.20%-42.35M -70.63%-36.02M -4.39%-131.37M 1.35%-36.52M
Net non-operating interest income expense 80.67%7.68M 89.22%7.4M 75.67%4.38M 266.95%14.9M 88.45%4.24M 267.50%4.25M 708.47%3.91M 1,382.74%2.49M 816.48%4.06M 1,745.08%2.25M
Non-operating interest income 80.67%7.68M 89.22%7.4M 75.67%4.38M 266.95%14.9M 88.45%4.24M 267.50%4.25M 708.47%3.91M 1,382.74%2.49M 816.48%4.06M 1,745.08%2.25M
Other net income (expense) 554.84%141K 610.53%97K 90.26%-19K -151.25%-201K -38.03%44K 63.95%-31K 75.64%-19K -1,600.00%-195K 46.31%-80K 646.15%71K
Other non- operating income (expenses) 554.84%141K 610.53%97K 90.26%-19K -151.25%-201K -38.03%44K 63.95%-31K 75.64%-19K -1,600.00%-195K 46.31%-80K 646.15%71K
Income before tax 1.39%-33.63M 18.64%-31.29M 724.66%210.67M 38.02%-78.96M 179.94%27.34M -9.20%-34.11M 6.28%-38.46M -61.13%-33.73M -1.47%-127.39M 7.35%-34.19M
Income tax -420K -676K 3.33M 0 0 0
Net income 2.62%-33.21M 20.40%-30.62M 714.80%207.34M 38.02%-78.96M 179.94%27.34M -9.20%-34.11M 6.28%-38.46M -61.13%-33.73M -1.47%-127.39M 7.35%-34.19M
Net income continuous Operations 2.62%-33.21M 20.40%-30.62M 714.80%207.34M 38.02%-78.96M 179.94%27.34M -9.20%-34.11M 6.28%-38.46M -61.13%-33.73M -1.47%-127.39M 7.35%-34.19M
Minority interest income
Net income attributable to the parent company 2.62%-33.21M 20.40%-30.62M 714.80%207.34M 38.02%-78.96M 179.94%27.34M -9.20%-34.11M 6.28%-38.46M -61.13%-33.73M -1.47%-127.39M 7.35%-34.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.62%-33.21M 20.40%-30.62M 714.80%207.34M 38.02%-78.96M 179.94%27.34M -9.20%-34.11M 6.28%-38.46M -61.13%-33.73M -1.47%-127.39M 7.35%-34.19M
Basic earnings per share 6.90%-0.54 26.47%-0.5 608.96%3.41 46.54%-1.39 165.22%0.45 9.38%-0.58 19.05%-0.68 -55.81%-0.67 4.06%-2.6 10.39%-0.69
Diluted earnings per share 6.90%-0.54 26.47%-0.5 586.57%3.26 46.54%-1.39 163.77%0.44 9.38%-0.58 19.05%-0.68 -55.81%-0.67 4.06%-2.6 10.39%-0.69
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Toll Brothers
TOL
+2.56%
Meritage Homes
MTH
+2.34%
Taylor Morrison Home
TMHC
+1.58%
D.R. Horton
DHI
+1.49%
KB Home
KBH
+1.35%

Unlock the Full List